Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Academician O. Ghudusha… | Healthcare Services | 26.4% | 87th pct | 268 |
| BROTHERS | Healthcare Services | 15.8% | 67th pct | 268 |
| West Georgia Medical Ce… | Healthcare Services | 15.6% | 66th pct | 268 |
| American Hospital Netwo… | Healthcare Services | — | no FY data | 268 |
| High Medical Technologi… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 3 of 5 peers filed FY2024. Switch to FY2022 (5 of 5).
| Ratio — FY 2024 | Academician O. Ghudusha… | West Georgia Medical Ce… | BROTHERS | American Hospital Netwo… | High Medical Technologi… |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 68.7% | 29.7% | 29.8% | — | — |
| EBITDA Margin | 26.4% | 15.6% | 15.8% | — | — |
| EBITDAR | 12,374 | 7,141 | 5,919 | — | — |
| EBITDAR Margin | 26.4% | 15.6% | 15.8% | — | — |
| EBIT Margin | 21.0% | 9.7% | 15.8% | — | — |
| Net Profit Margin | 23.6% | 17.0% | -0.7% | — | — |
| Operating Expense % of Sales | 42.2% | 15.4% | 14.0% | — | — |
| Returns | |||||
| Return on Assets (ROA) | 13.2% | 7.8% | -0.7% | — | — |
| Return on Equity (ROE) | 13.9% | 9.1% | N/A | — | — |
| ROIC [EBIT / Invested Capital] | 13.8% | 5.4% | 19.0% | — | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 0.0% | 0.0% | 130.9% | — | — |
| Debt-to-Equity | 0.00x | 0.00x | -2.88x | — | — |
| Debt-to-EBITDA | 0.00x | 0.00x | 8.48x | — | — |
| Equity-to-Assets | 95.4% | 85.3% | -45.5% | — | — |
| Net Debt | -8,544 | -1,865 | 48,546 | — | — |
| Cash & Equivalents | 8,544 | 1,865 | 1,676 | — | — |
| Total Debt | N/A | N/A | 50,222 | — | — |
| Liquidity & working capital | |||||
| Current Ratio | 4.20x | 1.56x | 0.52x | — | — |
| Quick Ratio | 3.44x | 1.29x | 0.42x | — | — |
| Cash Ratio | 2.20x | 0.13x | 0.09x | — | — |
| Total Current Assets | 16,308 | 22,705 | 9,908 | — | — |
| Total Current Liabilities | 3,879 | 14,591 | 18,925 | — | — |
| Inventory | 2,946 | 3,931 | 1,984 | — | — |
| Trade Receivables | 4,819 | 11,888 | 6,247 | — | — |
| Trade Payables | 2,696 | 1,958 | 3,572 | — | — |
| Net Working Capital | 12,429 | 8,114 | -9,018 | — | — |
| Net Working Capital % of Revenue | 26.6% | 17.7% | -24.1% | — | — |
| Trade Working Capital | 5,068 | 13,861 | 4,660 | — | — |
| Trade Working Capital % of Revenue | 10.8% | 30.3% | 12.4% | — | — |
| Change in Trade Working Capital | N/A | N/A | N/A | — | — |
| Turnover & efficiency | |||||
| Inventory Turnover | 4.98x | 8.18x | 13.25x | — | — |
| Days Inventory Outstanding (DIO) | 73.3 | 44.6 | 27.6 | — | — |
| Receivables Turnover | 9.71x | 3.85x | 5.99x | — | — |
| Days Sales Outstanding (DSO) | 37.6 | 94.9 | 60.9 | — | — |
| Payables Turnover | 5.44x | 16.41x | 7.36x | — | — |
| Days Payable Outstanding (DPO) | 67.1 | 22.2 | 49.6 | — | — |
| Cash Conversion Cycle | 43.8 days | 117.3 days | 38.8 days | — | — |
| Asset Turnover | 0.56x | 0.46x | 0.98x | — | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | 16,458 | 11,560 | 4,634 | — | — |
| Free Cash Flow (OCF − Capex proxy) | 17,395 | 1,526 | 4,694 | — | — |
| Cash Conversion (OCF / EBITDA) | 133.0% | 161.9% | 78.3% | — | — |
| Dividends Declared | 21,951 | 8,806 | 0 | — | — |
| Dividend Payout Ratio | 198.8% | 113.6% | N/A | — | — |